Ahrens Brenton Karl

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 83% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ahrens Brenton Karl's trades of Iterum Therapeutics PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-20 2022-09-20
S Sale
28,356 +25.4%
360.78
US$2,549,065 		28,356 +25.4% 360.78 US$2,549,065
2022-09-20 2022-09-19
S Sale
20,191 -48.0%
388.65
US$2,757,496 		20,191 -48.0% 388.65 US$2,757,496
2022-09-20 2022-09-16
S Sale
15,487 -4.1%
480.70
US$3,752,678 		15,487 -4.1% 480.70 US$3,752,678
2022-09-15 2022-09-15
S Sale
15,000 -28.7%
2.02
US$30,272 		15,000 -28.7% 2.02 US$30,272
2022-09-15 2022-09-14
S Sale
15,000 -22.3%
2.10
US$31,456 		15,000 -22.3% 2.10 US$31,456
2022-09-15 2022-09-13
S Sale
15,000 -18.2%
2.14
US$32,118 		15,000 -18.2% 2.14 US$32,118
2022-09-12 2022-09-12
S Sale
15,000 -15.4%
2.31
US$34,608 		15,000 -15.4% 2.31 US$34,608
2022-09-12 2022-09-09
S Sale
15,000 -13.4%
2.32
US$34,730 		15,000 -13.4% 2.32 US$34,730
2022-09-12 2022-09-08
S Sale
3,298 -2.9%
2.26
US$7,465 		3,298 -2.9% 2.26 US$7,465